Xerostomia (Dry Mouth Disease) Therapeutics Market - Global Industry Trends, Share, Size, Growth, Opportunities and Forecasts, 2022-2023 & 2028
08 nov. 2023 05h18 HE
|
Research and Markets
Dublin, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The "Xerostomia (Dry Mouth Disease) Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been...
Global Autoimmune Collaboration and Licensing Deals Analysis Report and Directory 2023
07 nov. 2023 04h53 HE
|
Research and Markets
Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The "Autoimmune Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering. The "Autoimmune Collaboration...
Cloud Gaming's Meteoric Rise: How 5G and Cutting-Edge Tech are Transforming the Gaming Landscape
02 nov. 2023 08h18 HE
|
Research and Markets
Dublin, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The "Opportunity Assessment of Cloud Gaming Evolution in the 5G and 6G Era" report has been added to ResearchAndMarkets.com's offering. The cloud gaming...
Global CD3 Antibodies Market 2023-2028: New-Generation CD3 Antibodies Targeting Diverse Indications Gain Ground
02 nov. 2023 07h43 HE
|
Research and Markets
Dublin, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The "Global CD3 Antibodies Market, Dosage, Price, Sales & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. ...
JAK Inhibitors Market Surges as Autoimmune Diseases Demand Cutting-Edge Solutions, 2032F: Revenues for Ruxolitinib, Tofacitinib, Oclacitinib, Baricitinib, Peficitinib, and Other Inhibitor Types
01 nov. 2023 08h18 HE
|
Research and Markets
Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Janus Kinase (JAK) Inhibitors Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global Janus Kinase (JAK)...
Acute Myeloid Leukemia (AML) Therapeutics Market Set to Reach $3.7 Billion by 2032: New Pipeline Agents Drive Growth
31 oct. 2023 08h58 HE
|
Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032" report has been added to ...
Technological Advancements and Increasing Prevalence of Arthritis Drive Innovation in the Global Aspirin Market
24 oct. 2023 04h08 HE
|
Research and Markets
Dublin, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The "Aspirin Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global aspirin market is expected to experience...
Global Tofacitinib Market Research Report 2023
17 oct. 2023 05h18 HE
|
Research and Markets
Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The "Tofacitinib Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global tofacitinib market is expected to grow...
United States Bispecific Antibodies Market & Clinical Pipeline Research Report 2023: Potential Market Opportunity of $15 Billion By 2028 - Dosage, Price and Sales Insights
16 oct. 2023 07h03 HE
|
Research and Markets
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The "US Bispecific Antibodies Market & Clinical Pipeline Insight 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. The US...
Addressing Unmet Needs: The SLE Market Grows as Research and Development Flourish
06 oct. 2023 06h08 HE
|
Research and Markets
Dublin, Oct. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Systemic Lupus Erythematosus (SLE) Market (by Product Type, Route of Administration, End User, & Region): Insights & Forecast with...